In the context of the Covid-19 pandemic, Neurochlore is doing everything in its power to continue its research activities and is participating in the effort to fight the virus and help patients.

The Covid-19 pandemic disrupted our activities and put a serious brake on our laboratory work. We were forced to completely stop our laboratory experiments and the majority of researchers and technicians are now teleworking. The research does not stop : data analysis, discussion of results, writing of future publications, bibliography, by communicating with each other thanks to the digital tools that we have implemented.

In these difficult times, it seems more important than ever:

  • Above all to preserve the health of our employees and help manage this pandemic by limiting their contact and movements as much as possible.
  • To take advantage of confinement to take the time to discuss our scientific projects and select those that seem to us the most relevant and innovative.
  • To help the health personnel at our level, by distributing them our stocks of masks, gloves and protections.
  • To participate in discussions on the web and in the media on the lessons to be learned from this pandemic for the future.

In these times of crisis, our thoughts are with the health personnel, who are showing great strength, as well as all those who work for our food or other goods, as well as all those affected directly or indirectly by this pandemic.

Yehezkel Ben-Ari & Constance Hammond, President and CEO of Neurochlore

Understanding and treating developmental brain disorders.

 
What we do

Clinical Research

Clinical Research is organized around a net of psychiatrists and pediatricians in Brittany…
Learn more

What we do

Fundamental Research

Fundamental Research is organized around a wide range of animal models –including ASD…
Learn more

Who we are

People

Discover the many faces behind neurochlore’s major scientific breakthroughs…
Learn more

They talk about us

News and Media

Neurochlore in the media:
Press publications, news and interviews…
Learn more